OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ABI2‐mediated MEOX2/KLF4‐NANOG axis promotes liver cancer stem cell and drives tumour recurrence
Jiandi Chen, Huizi Li, Bin Zhang, et al.
Liver International (2022) Vol. 42, Iss. 11, pp. 2562-2576
Open Access | Times Cited: 22

Showing 22 citing articles:

Cancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 92

Molecular targets, therapeutic agents and multitasking nanoparticles to deal with cancer stem cells: A narrative review
Abolfazl Doustmihan, Marziyeh Fathi, MirAhmad Mazloomi, et al.
Journal of Controlled Release (2023) Vol. 363, pp. 57-83
Open Access | Times Cited: 36

The tumor microenvironment in the postsurgical liver: Mechanisms and potential targets of postoperative recurrence in human hepatocellular carcinoma
Junyu Wu, Yau‐Tuen Chan, Yuanjun Lu, et al.
Medicinal Research Reviews (2023) Vol. 43, Iss. 6, pp. 1946-1973
Open Access | Times Cited: 24

Disulfidptosis decoded: a journey through cell death mysteries, regulatory networks, disease paradigms and future directions
Jinyu Chen, Boyuan Ma, Yubiao Yang, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 11

Potential targets and therapeutics for cancer stem cell-based therapy against drug resistance in hepatocellular carcinoma
Hongxing Zhao, Yuhang Ling, Jie He, et al.
Drug Resistance Updates (2024) Vol. 74, pp. 101084-101084
Closed Access | Times Cited: 8

The role of ABI2 in modulating nuclear proteins: Therapeutic implications for NUP54 and NUP153 in TNBC
Santhosh Mudipalli Elavarasu, Karthick Vasudevan, K. Sasikumar, et al.
Advances in protein chemistry and structural biology (2025), pp. 97-115
Closed Access

KLF4: a multifunctional nexus connecting tumor progression and immune regulation
Ying Ju, Wen Xiao, Bryan J. Mathis, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access

MEOX2 mediates cisplatin resistance in ovarian cancer via E2F target and DNA repair pathways
Fei Wang, Han Zhang, Xiru Liu, et al.
Journal of Ovarian Research (2025) Vol. 18, Iss. 1
Open Access

Element-specific estimation of background mutation rates in whole cancer genomes through transfer learning
Farideh Bahari, Reza Ahangari Cohan, Hesam Montazeri
npj Precision Oncology (2025) Vol. 9, Iss. 1
Open Access

Transcriptional regulation of cancer stem cell: regulatory factors elucidation and cancer treatment strategies
Zhengyue Zhang, Yanjie Zhang
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 3

EphA2 promotes the transcription of KLF4 to facilitate stemness in oral squamous cell carcinoma
Junqiang Bai, Yang Chen, Yunqing Sun, et al.
Cellular and Molecular Life Sciences (2024) Vol. 81, Iss. 1
Open Access | Times Cited: 3

Inhibition of ABI2 ubiquitination-dependent degradation suppresses TNBC cell growth via down-regulating PI3K/Akt signaling pathway
Linlin Lv, Shujing Li, Jie Kang, et al.
Cancer Cell International (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2

Function of TRPC1 in modulating hepatocellular carcinoma progression
Huimin Qi, Fengming Wu, Hongmei Wang
Medical Oncology (2023) Vol. 40, Iss. 3
Closed Access | Times Cited: 6

FTO Promotes the Stemness of Gastric Cancer Cells
Mengqing Li, Xuan Wu, Li Guan, et al.
DNA and Cell Biology (2023) Vol. 42, Iss. 7, pp. 411-420
Closed Access | Times Cited: 4

The HHEX-ABI2/SLC17A9 axis induces cancer stem cell-like properties and tumorigenesis in HCC
Huizi Li, Jin Liu, Jie Lai, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1

Hemoglobin nanoclusters-mediated regulation of KPNA4 in hypoxic tumor microenvironment enhances photodynamic therapy in hepatocellular carcinoma
Yiliang Wang, Nu Li, Letian Qu, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1

The COL7A1/PI3K/AKT axis regulates the progression of cholangiocarcinoma
Yang Ma, Yanfang Zhang, Fangfang Chen, et al.
Heliyon (2024), pp. e37361-e37361
Open Access

Disulfidptosis-related signature to guide the prognosis prediction and treatment in hepatocellular carcinoma
Yuanzhi Zhou, Wenwen Chen, Xu Zhang, et al.
Research Square (Research Square) (2023)
Open Access

Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency
Nikolaos Bekas, Martina Samiotaki, Maria Papathanasiou, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4997-4997
Open Access

Transcriptome heterogeneity of congenital cleft palate model in congener New Zealand rabbits induced by dexamethasone.
Lanling Lin, Haoyue Liu, Xiao Luo, et al.
PubMed (2023) Vol. 41, Iss. 1, pp. 37-42
Closed Access

Page 1

Scroll to top